Arbuckle Stuart A 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 28, 2025
Insider Transaction Report
Form 4
Arbuckle Stuart A
EVP\Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2025-02-26$479.61/sh−7,071$3,391,322→ 62,935 total
Holdings
- 140(indirect: By 401(k))
Common Stock